References
- United States Food and Drug Administration. Summary of labeling changes. Available at: www.fda.gov/medwatch/ SAFETY/2002/safety02.htm#cytote. Accessed October 2, 2003.
- Hofmeyer GJ, Gulmezoglu AM. Vaginal misoprostol for cervical ripening and induction of labour (Cochrane Review). In: The Cochrane Library, Issue 1. Chichester, UK: John Wiley and Sons Ltd; 2004.
- Sanchez-Ramos L, Kaunitz AM. Misoprostol for cervical ripening and labor induction: A systematic review of the literature. Clin Obstet Gynecol 2000;43:475–488.
- Zieman M., Fang SK, Benowitz NL, Bankster D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997;90:88–92.
- Whitecar PW, Zwiefel A, Moise KJ. Failed second trimester misoprostol termination responding to vaginal instillation of citric acid. Obstet Gynecol 1999;94:839.
- Ramsey PS. Ogburn PL, Harris DY, Heise RH, Ramin KD. Effect of vaginal pH on efficacy of misoprostol for cervical ripening and labor induction. Am J Obstet Gynecol 2000;182:1616–1619.
- Gunalp S, Bildirici I. The effect of vaginal pH on the efficacy of vaginal misoprostol for induction of labor. Acta Obstet Gynecol Scand 2000;79:283–285.
- American College of Obstetricians and Gynecologists. Induc-tion of labor. Practice Bulletin 1999;10:1–10.
- Curtis P, Evens S, Resnick J. Uterine hyperstimulation: The need for standard terminology. J Reprod Med 1987;32:91–95.
- American College of Obstetricians and Gynecologists. In-appropriate use of the terms fetal distress and birth asphyxia. ACOG Committee Opinion 1998:197:1–2.
- Wing DA, Jones MM, Rabal A, Goodwin TM, Paul RH. A comparison of misoprostol and prostaglandin E2 for pre-induction cervical ripening and labor induction. Am J Obstet Gynecol 1995;172: 1804–1810.
- Wing DA, Jones MM, Rabal A, Goodwin TM, Paul RH. Misoprostol: An effective agent for cervical ripening and labor induction. Am J Obstet Gynecol 1995;172:1811–1816.
- Karim A, Rozek LF, Smith ME, Kowalski KG. Effects of food and antacid on oral absorption of misoprostol, a synthetic prostaglandin Ei analog. J Chin Pharmacol 1989;29:439–443.
- Carey JC, Klebanoff MA. What have we learned about vaginal infections and preterm birth? Semin Perinatol 2003;27:212–216.
- Myles TD, Gooch J, Santolaya J. Obesity as an independent risk factor for infectious morbidity in patients who undergo cesarean delivery. Obstet Gynecol. 2002 Nov;100:959–64.
- Singh K, Fong YF, Prasad RNV, Dong F. Does an acidic medium enhance the efficacy of vaginal misoprostol for preabortion cervical priming? Human Reprod 1999;14: 1635-1637.
- Sanchez-Ramos L, Danner CJ, Delke I, Kaunitz AM. The effect of tablet moistening on labor induction with intravaginal misoprostol: A randomized trial. Obstet Gynecol 2002;99: 1080–1084.